Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:diseases:ankylosing_spondylitis [01.11.2019] – [Doctor's report] sallieqhome:diseases:ankylosing_spondylitis [01.11.2019] – [Doctor's report] sallieq
Line 28: Line 28:
 Injections usually used are seriously immune suppressant  Injections usually used are seriously immune suppressant 
 [[https://medlineplus.gov/druginfo/meds/a608041.html|Certolizumab ]], [[https://medlineplus.gov/druginfo/meds/a603010.html|Adalimumab ]], [[https://medlineplus.gov/druginfo/meds/a604023.html|Infliximab]] [[https://medlineplus.gov/druginfo/meds/a608041.html|Certolizumab ]], [[https://medlineplus.gov/druginfo/meds/a603010.html|Adalimumab ]], [[https://medlineplus.gov/druginfo/meds/a604023.html|Infliximab]]
 +
 +
 +===== Doctor's report on MP treatment =====
 +
 +
 +[[home:publications:blaney_autoimmunity_2010|Blaney: congress on autoimmunity 2010]]
 +
 +
 +<blockquote>
 +Case 1 is ankylosing spondylitis in a now 50 year old male. Onset was at the age of 26, initially as sacroiliitis. It progressed in a typical fashion with increasing rigidity of the spine, fusion of cervical facet joints, pain and fatigue. He also developed co-morbid conditions including chronic prostatitis, neuropathy, irritable bowel syndrome, insomnia and depression. He was unable to work full time.  He started treatment December 2005.
 +
 +He experienced waxing and waning of symptoms both physical and emotional through the first 3 years of treatment, peaking in mid 2007. Presently he is no longer depressed and is back working full time in international finance. His prostatitis has cleared as has his IBS. Bone density increased 11% in his femur and 5% in his lumbar vertebrae over the last 2 years. His Bath Ankylosing spondylitis Disease Activity Index which had risen from 8.8 to 9.2 is now 5.3.</blockquote> 
 +
 +
 +{{tag>diseases arrange}}
  
  
Line 74: Line 89:
 <blockquote> I was on Fosamax for 2 years, which lead to acid reflux and the need for Prilosec.  My primary doc was obviously wrong then, as I believe he is now when he recommends 1000mg of Vitamin D daily.  Been there and done that already with very bad results.  I don't argue with my doc, but I make my own educated health decisions.  Most of our current medical insight seems to be blinded by the "sunshine vitamin syndrome" //Jasmine//</blockquote> <blockquote> I was on Fosamax for 2 years, which lead to acid reflux and the need for Prilosec.  My primary doc was obviously wrong then, as I believe he is now when he recommends 1000mg of Vitamin D daily.  Been there and done that already with very bad results.  I don't argue with my doc, but I make my own educated health decisions.  Most of our current medical insight seems to be blinded by the "sunshine vitamin syndrome" //Jasmine//</blockquote>
  
-===== Doctor's report ===== 
- 
- 
-[[home:publications:blaney_autoimmunity_2010|Blaney: congress on autoimmunity 2010]] 
- 
- 
-<blockquote> 
-Case 1 is ankylosing spondylitis in a now 50 year old male. Onset was at the age of 26, initially as sacroiliitis. It progressed in a typical fashion with increasing rigidity of the spine, fusion of cervical facet joints, pain and fatigue. He also developed co-morbid conditions including chronic prostatitis, neuropathy, irritable bowel syndrome, insomnia and depression. He was unable to work full time.  He started treatment December 2005. 
- 
-He experienced waxing and waning of symptoms both physical and emotional through the first 3 years of treatment, peaking in mid 2007. Presently he is no longer depressed and is back working full time in international finance. His prostatitis has cleared as has his IBS. Bone density increased 11% in his femur and 5% in his lumbar vertebrae over the last 2 years. His Bath Ankylosing spondylitis Disease Activity Index which had risen from 8.8 to 9.2 is now 5.3.</blockquote>  
  
 ==== Related research ==== ==== Related research ====
Line 90: Line 95:
  
 Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw   (({{pubmed>long:30534822}})) Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw   (({{pubmed>long:30534822}}))
 +
 + 
  
  
home/diseases/ankylosing_spondylitis.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.